Zafgen Company Profile (NASDAQ:ZFGN)

About Zafgen

Zafgen logoZafgen, Inc. is a biopharmaceutical company. The Company is focused on improving the health and well-being of patients affected by obesity and complex metabolic disorders. The Company's lead product candidate, Beloranib, is a twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including severe obesity in rare diseases, such as Prader-Willi syndrome (PWS) and hypothalamic injury-associated obesity (HIAO), including craniopharyngioma-associated obesity. Beloranib is in Phase III stage of development for PWS. It is also developing ZGN-839, a liver-targeted methionine aminopeptidase 2 (MetAP2) inhibitor, for the treatment of nonalcoholic steatohepatitis (NASH) and abdominal obesity, as well as other second-generation MetAP2 inhibitors for the treatment of severe obesity. It is also evaluating additional MetAP2 inhibitors beyond Beloranib as a development candidate for the treatment of severe obesity in the general population.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ZFGN
  • CUSIP:
Key Metrics:
  • Previous Close: $3.48
  • 50 Day Moving Average: $3.31
  • 200 Day Moving Average: $4.98
  • 52-Week Range: $27,329,000.00 - $2.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.64
  • P/E Growth: 0.00
  • Market Cap: $95.10M
  • Outstanding Shares: 27,329,000
  • Beta: -1.65
  • Return on Equity: -46.27%
  • Return on Assets: -42.04%
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 14.43%
  • Quick Ratio: 14.43%
Additional Links:
Companies Related to Zafgen:

Analyst Ratings

Consensus Ratings for Zafgen (NASDAQ:ZFGN) (?)
Ratings Breakdown: 4 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $16.83 (383.72% upside)

Analysts' Ratings History for Zafgen (NASDAQ:ZFGN)
DateFirmActionRatingPrice TargetDetails
9/20/2016FBR & CoReiterated RatingHoldView Rating Details
8/25/2016Cowen and CompanyReiterated RatingBuy$60.00View Rating Details
7/21/2016Canaccord GenuitySet Price TargetHold$7.00 -> $4.00View Rating Details
7/20/2016Leerink SwannReiterated RatingMarket Perform$6.00View Rating Details
4/5/2016Royal Bank Of CanadaReiterated RatingOutperform$19.00View Rating Details
2/20/2016SunTrust Banks Inc.Reiterated RatingHold$7.00View Rating Details
10/16/2015JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
(Data available from 10/23/2014 forward)


Earnings History for Zafgen (NASDAQ:ZFGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2016Q116($0.74)($0.65)ViewListenView Earnings Details
3/9/2016Q415($0.80)($0.85)ViewN/AView Earnings Details
11/10/2015Q3($0.79)($0.73)$80.60 million$78.20 millionViewListenView Earnings Details
8/11/2015Q215($0.71)($0.66)ViewListenView Earnings Details
5/12/2015Q115($0.52)($0.53)ViewListenView Earnings Details
3/19/2015Q414($0.84)($0.48)ViewListenView Earnings Details
11/11/2014Q314($0.87)($0.65)ViewN/AView Earnings Details
8/13/2014Q214($0.28)($2.96)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Zafgen (NASDAQ:ZFGN)
Current Year EPS Consensus Estimate: $-2.33 EPS
Next Year EPS Consensus Estimate: $-2.12 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.75)($0.75)($0.75)
Q2 20162($0.66)($0.62)($0.64)
Q3 20162($0.76)($0.68)($0.72)
Q4 20162($0.89)($0.69)($0.79)
(Data provided by Zacks Investment Research)


Dividend History for Zafgen (NASDAQ:ZFGN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Zafgen (NASDAQ:ZFGN)
Insider Ownership Percentage: 20.30%
Institutional Ownership Percentage: 62.87%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/29/2016Thomas E HughesInsiderBuy10,000$3.00$30,000.00View SEC Filing  
7/26/2016Patricia L. AllenCFOBuy16,000$3.12$49,920.00View SEC Filing  
7/22/2016Frances K HellerDirectorBuy10,000$2.99$29,900.00View SEC Filing  
7/22/2016Thomas E. HughesInsiderBuy5,000$3.02$15,100.00View SEC Filing  
2/12/2016James E FlynnInsiderBuy64,545$6.25$403,406.25View SEC Filing  
2/11/2016James E FlynnInsiderBuy267,493$6.02$1,610,307.86View SEC Filing  
9/24/2015Kevin P StarrDirectorSell136,579$43.90$5,995,818.10View SEC Filing  
9/18/2015Avi Y GoldbergDirectorSell5,000$45.00$225,000.00View SEC Filing  
9/18/2015Thomas E. HughesCEOSell45,626$42.53$1,940,473.78View SEC Filing  
9/17/2015Dennis D. KiminsiderSell39,407$40.00$1,576,280.00View SEC Filing  
6/10/2015Avi Y GoldbergDirectorSell3,000$35.00$105,000.00View SEC Filing  
6/1/2015Avi Y GoldbergDirectorSell2,000$32.23$64,460.00View SEC Filing  
6/19/2014Alicia SecorInsiderBuy4,000$20.00$80,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Zafgen (NASDAQ:ZFGN)
News IconSell-side Taking Aim at Shares of Zafgen, Inc. (NASDAQ:ZFGN) - CSZ News (NASDAQ:ZFGN) - October 21 at 11:55 AM
News IconRating Sentiment Worth Watching: How Analysts Rated Zafgen Inc (NASDAQ:ZFGN) Last Week? - MoneyMakingArticles (NASDAQ:ZFGN) - October 20 at 8:32 PM
News IconConsensus Estimates on Earnings & Stock Price in Focus for Zafgen, Inc. (NASDAQ:ZFGN) Shares - CSZ News (NASDAQ:ZFGN) - October 15 at 5:19 AM
News IconBroker Roundup For Zafgen, Inc. (NASDAQ:ZFGN) - The De Soto Edge (NASDAQ:ZFGN) - October 14 at 8:00 PM
News IconCandriam Luxembourg S.C.A. Maintains Position in Zafgen Inc. (ZFGN) - DailyQuint (NASDAQ:ZFGN) - October 11 at 8:00 PM
News IconStock Ballooning in Midday Session: Zafgen, Inc. (NASDAQ:ZFGN) - CSZ News (NASDAQ:ZFGN) - October 10 at 7:41 PM
News IconLatest Analyst Ratings For Zafgen, Inc. (NASDAQ:ZFGN) - The De Soto Edge (NASDAQ:ZFGN) - October 8 at 7:30 PM
News IconBroker Changes For Zafgen, Inc. (NASDAQ:ZFGN) - NewsDen (NASDAQ:ZFGN) - October 8 at 7:30 PM
News IconIs the Needle Ready to Move for Zafgen, Inc. (NASDAQ:ZFGN) - Yankee Analysts (NASDAQ:ZFGN) - October 7 at 7:53 PM
News IconDynamic Stock Hitting the Active List: Zafgen, Inc. (NASDAQ:ZFGN ... - Recall News (NASDAQ:ZFGN) - October 7 at 7:53 PM
News IconZafgen, Inc. (NASDAQ:ZFGN) Updated Analyst Coverage - NewsDen (NASDAQ:ZFGN) - October 5 at 8:02 PM
News IconStreet Session Update on Zafgen, Inc. (NASDAQ:ZFGN) - Recall News (NASDAQ:ZFGN) - October 3 at 7:38 PM
News IconZafgen, Inc. (NASDAQ:ZFGN) Updated Broker Price Targets - The De Soto Edge (NASDAQ:ZFGN) - October 1 at 6:43 AM
News IconEarnings Take Center Stage; Analysts Weighing in on Zafgen, Inc ... - Frisco Fastball (NASDAQ:ZFGN) - October 1 at 6:43 AM
News IconPrice Target in the Spotlight: Zafgen, Inc. (NASDAQ:ZFGN) - (NASDAQ:ZFGN) - September 23 at 5:01 AM
News IconInvestor's Alert: Zafgen, Inc. (NASDAQ:ZFGN), Harmonic Inc. (NASDAQ:HLIT) - Newburgh Press (NASDAQ:ZFGN) - September 23 at 5:01 AM
News IconZafgen Inc Increases Again; Strong Momentum for Buyers - Post News (NASDAQ:ZFGN) - September 22 at 5:04 AM logoZafgen : Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN-1061 (NASDAQ:ZFGN) - September 21 at 7:45 PM logoStock Update (NASDAQ:ZFGN): Zafgen Inc Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN ... - Smarter Analyst (NASDAQ:ZFGN) - September 21 at 12:03 PM logoZafgen, Inc. :ZFGN-US: Earnings Analysis: Q2, 2016 By the Numbers : September 20, 2016 (NASDAQ:ZFGN) - September 21 at 12:03 PM logoZafgen (ZFGN) Commences MAD Cohorts of ZGN-1061 Phase 1 - (NASDAQ:ZFGN) - September 20 at 8:33 AM logoZafgen Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN-1061 (NASDAQ:ZFGN) - September 20 at 8:33 AM
News IconMarket Review: Watching Session Activity of Zafgen, Inc. (NASDAQ:ZFGN) Shares - Post News (NASDAQ:ZFGN) - September 9 at 7:50 PM
News IconPlacing Zafgen, Inc. (NASDAQ:ZFGN) Shares Under the Microscope - National Daily Press (NASDAQ:ZFGN) - September 9 at 5:25 AM
News IconStock Tracker: Earnings & Estimates for Zafgen, Inc. (NASDAQ:ZFGN) - Frisco Fastball (NASDAQ:ZFGN) - September 8 at 12:10 PM
News IconZafgen Inc(NASDAQ:ZFGN) Upward Trend - Live Trading News (NASDAQ:ZFGN) - September 5 at 7:06 PM
News IconInvestors are Sharpening Their Focus on Shares of Zafgen, Inc. (NASDAQ:ZFGN) - Post News (NASDAQ:ZFGN) - August 31 at 5:28 AM
News IconStocks Trending Alert: Zafgen Inc (NASDAQ:ZFGN), Xtera Communications Inc (NASDAQ:XCOM), Yahoo! Inc ... - NYSE Journal (press release) (NASDAQ:ZFGN) - August 29 at 8:20 PM logoZafgen: Too Cheap To Ignore - Seeking Alpha (NASDAQ:ZFGN) - August 26 at 11:17 AM
News IconWorth Watching Stocks in the Spotlight: Zafgen Inc (NASDAQ:ZFGN), Pan American Silver Corp. (USA) (NASDAQ:PAAS) - NYSE Journal (press release) (NASDAQ:ZFGN) - August 23 at 8:32 PM logoZAFGEN, INC. Financials (NASDAQ:ZFGN) - August 13 at 7:51 PM
News IconActive Runners: Intermolecular Inc (NASDAQ:IMI), Zafgen Inc ... - NYSE Journal (press release) (NASDAQ:ZFGN) - August 8 at 8:39 PM logoZAFGEN, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ZFGN) - August 5 at 11:32 AM logoZafgen Inc.: Zafgen Reports Second Quarter 2016 Financial Results (NASDAQ:ZFGN) - August 4 at 8:54 PM logoZafgen reports 2Q loss (NASDAQ:ZFGN) - August 4 at 8:54 PM logoZafgen to Present at Canaccord Genuity’s 36th Annual Growth Conference (NASDAQ:ZFGN) - August 3 at 8:49 PM logoZFGN: Insiders vs. Shorts (NASDAQ:ZFGN) - July 30 at 3:16 PM logoAnalysts: Zafgen, Inc. (NASDAQ:ZFGN) stock is worth $4.5 ... - Review Fortune (NASDAQ:ZFGN) - July 29 at 8:43 PM logoZafgen (ZFGN) Is in Oversold Territory: What's Next? (NASDAQ:ZFGN) - July 29 at 9:53 AM
News IconHot Biotech Stocks Recap: Zafgen, Inc. (NASDAQ:ZFGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - The Voice Registrar (NASDAQ:ZFGN) - July 28 at 8:56 PM
News IconHC Stocks Overview: Celgene Corporation (NASDAQ:CELG) Zafgen Inc (NASDAQ:ZFGN) - share market updates (press release) (NASDAQ:ZFGN) - July 25 at 8:38 PM logoCurrent Zafgen, Inc. (NASDAQ:ZFGN) PT Means Stock Is Worth Almost $6 - Review Fortune (NASDAQ:ZFGN) - July 25 at 8:38 PM logoZafgen (ZFGN) Shares are Down -55.84% - Trade Calls (NASDAQ:ZFGN) - July 25 at 5:16 AM logoNoteworthy Analysts Suggestions: Zafgen, Inc. (NASDAQ:ZFGN) , St. Jude Medical, Inc. (NYSE:STJ) - Street Updates (NASDAQ:ZFGN) - July 25 at 5:16 AM
News IconShares Stumbling of Late: Zafgen, Inc. (NASDAQ:ZFGN) - TGP (NASDAQ:ZFGN) - July 23 at 9:40 AM logoOption Market: Zafgen Inc (NASDAQ:ZFGN) Risk Hits An Extreme High - CML News (NASDAQ:ZFGN) - July 22 at 8:13 PM logoZafgen, Inc. (NASDAQ:ZFGN) Insiders Look Optimistic About Prospects - Review Fortune (NASDAQ:ZFGN) - July 22 at 8:13 PM logoZafgen Inc. (ZFGN) is Trading Lower on Unusual Volume for July 21 - (NASDAQ:ZFGN) - July 22 at 8:13 PM
News IconBiotech Stocks To Put On Your Watch List: Zafgen, Inc. (NASDAQ:ZFGN), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NASDAQ:ZFGN) - July 22 at 11:22 AM
News IconWorthy Stock Update: Zafgen (ZFGN) - News Oracle (NASDAQ:ZFGN) - July 22 at 11:22 AM


Zafgen (NASDAQ:ZFGN) Chart for Sunday, October, 23, 2016

Last Updated on 10/23/2016 by Staff